AzTrials
AzTrials

To Evaluate Lower Urinary Tract Symptoms (LUTS) and Their Impact on Quality of Life in Night WorkersNCT04124874

Prevalence and Impact on Quality of Life of Lower Urinary Tract Symptoms (LUTS) in Night Workers

An observational study of To Evaluate Lower Urinary Tract Symptoms (LUTS) and Their Impact on Quality of Life in Night Workers, run by Jagiellonian University at 1 site in Poland.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The first large population-based study to evaluate lower urinary tract symptoms and their impact on quality of life in night workers. Read more about this study

Who is it for?
Ages 18 to 80 years
How many people
10,000 participants
Where
1 sitePoland
Study dates
15 Oct 2019to 1 Dec 2020
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • Adult, Older adult

Study population: Night workers defined as any workers, who, during night time, work at least three hours of their daily working time as a normal course or who work at night at least 1/4 of their working time during the accounting period (definition by the Polish Labour Code).

Who may be able to join

  • Night workers defined as any workers, who, during night time, work at least three hours of their daily working time as a normal course or who work at night at least 1/4 of their working time during the accounting period (definition by the Polish Labour Code).

Who cannot join

  • Non night workers Urinary tract infection in the past 4 weeks

Trial locations and contacts

1 site in 1 country.

Poland1 site
  • Department of Urology Jagiellonian University

    Krakow

Other trials in Poland

About this study

The first large population-based study to evaluate lower urinary tract symptoms and their impact on quality of life in night workers.

Read the detailed description

The first large population-based study to evaluate lower urinary tract symptoms (LUTS) and their impact on quality of life in night workers. The study objective is to assess the prevalence and bother of LUTS in the population of night workers.

This study will be conducted as a questionnaire survey with assessment of LUTS using a standardized protocol based on definitions by the International Continence Society (ICS). The International Prostate Symptom Score (IPSS), the Overactive Bladder- Validated 8-question Screener (OAB-V8), the Patient Health Questionnaire-9 (PHQ-9), the Athen Insomnia Scale, the Work Productivity and Activity Impairment Questionnaire (WPAI), the 12-Item Short Form Health Survey (SF-12) questionnaires will be included. Participants will be also asked to rate how often they experienced individual LUTS and the degree of associated bother.

Being tested
There will be no intervention

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • There will be no interventionOther

    There will be no intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Prevalence of LUTS

    The prevalence of LUTS will be assessed using definitions of the International Continence Society (descriptive statistics).

    Measured: Through study completion, an average of 3 months

  2. Symptom bother of LUTS

    The degree of associated bother will be assessed using Likert scale (Likert scale: not at all [score 0], a little bit [score 1], somewhat [score 2], quite a bit [score 3], a great deal [score 4], or a very great deal [score 5]).

    Measured: Through study completion, an average of 3 months

Secondary outcomes (7)
  1. Prevalence of specific lower urinary tract symptoms

    The prevalence of specific lower urinary tract symptoms will be assessed using a standardised protocol based on the definitions provided by the International Continence Society (i.e. storage symptoms, voiding symptoms and post-micturition symptoms).

    Measured: Through study completion, an average of 3 months

  2. Symptom bother of specific lower urinary tract symptoms

    The degree of associated bother of specific lower urinary tract symptoms will be assessed using Likert scale (Likert scale: not at all [score 0], a little bit [score 1], somewhat [score 2], quite a bit [score 3], a great deal [score 4], or a very great deal [score 5]).

    Measured: Through study completion, an average of 3 months

  3. Prevalence of OAB

    The prevalence of OAB will be assessed with the Overactive Bladder-Validated 8-question Screener (OAB- V8) questionnaire.

    Measured: Through study completion, an average of 3 months

  4. Prevalence of depressive symptoms

    The prevalence of depressive symptoms will be assessed with the PHQ-9 (Patient Health Questionnaire-9).

    Measured: Through study completion, an average of 3 months

  5. Sleep quality

    The sleep quality will be assessed with the Athen Insomnia Scale questionnaire.

    Measured: Through study completion, an average of 3 months

  6. Work productivity

    The work productivity will be assessed with the Work Productivity and Activity Impairment Questionnaire (WPAI).

    Measured: Through study completion, an average of 3 months

  7. General quality of life

    The general quality of life will be assessed with the 12-Item Short Form Health Survey (SF-12).

    Measured: Through study completion, an average of 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Oct 2019
  2. Study start15 Oct 2019
  3. Primary completion31 Dec 2019
  4. Study completion1 Dec 2020 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
10,000 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04124874
Sponsor's protocol ID
1072.6120.200.2019
Status last verified
Mar 2020
First submitted
10 Oct 2019
Last updated
30 Mar 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of To Evaluate Lower Urinary Tract Symptoms (LUTS) and Their Impact on Quality of Life in Night Workers, run by Jagiellonian University at 1 site in Poland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 30 Mar 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Poland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Prevalence of LUTS (time frame: Through study completion, an average of 3 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Mar 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in